In response to "Drug metabolizing enzyme polymorphisms predict clinical outcome in a node-positive breast cancer cohort".
Angela
A
DeMichele
Phyllis
P
Gimotty
Jeffrey
J
Botbyl
Richard
R
Aplenc
Theresa
T
Colligon
Andrea S
AS
Foulkes
Timothy R
TR
Rebbeck
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy / Q000201:enzymology*; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000378:metabolism; D003577:Cytochrome P-450 Enzyme System / Q000235:genetics*; D018572:Disease-Free Survival; D005260:Female; D005982:Glutathione Transferase / Q000235:genetics*; D006801:Humans; D008207:Lymphatic Metastasis; D009364:Neoplasm Recurrence, Local; D020641:Polymorphism, Single Nucleotide
D003520:Cyclophosphamide; D003577:Cytochrome P-450 Enzyme System; D005982:Glutathione Transferase